The findings in our study are important as we firstly demonstrate that radiomics signatures of CECT in cooperation with clinical characteristics are useful in predicting the efficacy of the three domestically developed PD-1 antibodies in treating Chinese HCC patients. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.